BaroFold, Inc. and Lonza Inc. Announce a Technology Evaluation Agreement for PreEMT, a High Pressure Protein Refolding Technology
1/16/2013 9:12:19 AM
AURORA, Colo. & BASEL, Switzerland--(BUSINESS WIRE)--Lonza, a leader in biological development, and BaroFold, Inc., an innovative protein technology developer, announced today a non-exclusive technology and license agreement whereby Lonza will evaluate BaroFold’s PreEMT™ high pressure refolding technology for use in biological development refolding processes. Lonza’s evaluation will focus on refolding difficult to express microbial products expressed as inclusion bodies. The PreEMT™ unit will be installed for evaluation at Lonza’s microbial development and manufacturing plant in Visp, Switzerland. The agreement includes an option for Lonza to extend the platform evaluation to cGMP production analysis.
comments powered by